
	Where results make sense

Topic: Memantine

	Memantine research
		Memantine protects the brain’s nerve cells against glutamate which is released in excess amounts by cells damaged by Alzheimer’s disease.
		Memantine can be taken with other Alzheimer’s drugs such as Aricept
		Memantine treatment of pain after amputation or surgery
	www.memantine.info (317 words)

	Encyclopedia article: Memantine (Site not responding. Last check: 2007-10-15)
		Memantine is an NMDA receptor (additional info and facts about NMDA receptor) antagonist (A drug that neutralizes or counteracts the effects of another drug) used in the treatment of Alzheimer's disease (additional info and facts about Alzheimer's disease).
		The low-affinity of memantine, however, preserves the physiological function of the receptor as it can still be activated by the relatively high concentrations of glutamate (A salt or ester of glutamic acid) released following depolarisation (A loss of polarity or polarization) of the presynaptic (additional info and facts about presynaptic) neuron.
		Memantine is indicated for the treatment of the symptoms of moderately severe to severe Alzheimer's disease (additional info and facts about Alzheimer's disease).
	www.absoluteastronomy.com /encyclopedia/m/me/memantine.htm (646 words)

	MedlinePlus Drug Information: Memantine (Systemic) (Site not responding. Last check: 2007-10-15)
		Memantine (me-MAN-teen) is used to treat moderate to severe Alzheimer's disease.
		Memantine is not a cure for Alzheimer's disease but it can help people with the disease.
		However, memantine has not been shown to cause birth defects or other problems in animal studies.
	www.nlm.nih.gov /medlineplus/druginfo/uspdi/500493.html (1066 words)

	memantine.com - Innovation for Alzheimer Patients
		Swedish scientist and professor, Professor Dr. Agneta Nordberg of Karolinska University in Stockholm received the Alois Alzheimer Award (AAA) for the outstanding work of her lifetime performed in Alzheimer’s dementia research.
		Memantine is the first representative of a new class of Alzheimer drugs – a moderate affinity NMDA-receptor antagonist.
		Download a live recording of Dr. Jeffrey Cummings, inventor of the NPI scale, discussing "relevance, assessment, and treatment of behavioral disturbances in Alzheimer's disease"
	www.memantine.com (242 words)

Try your search on: Qwika (all wikis)